Latest / Health & Veritas: Yale's Healthcare and Health Policy Podcast
Science, Politics, and Personality
Howie and Harlan discuss Dr. Vinay Prasad's departure from the FDA after a backlash against his decisions on Sarepta's Duchenne muscular dystrophy gene therapy. Also examined: AI in clinical settings, changes in NIH grantmaking, and the 60th anniversary of Medicare and Medicaid.
Links:
Sarepta and the FDA
"STAT breaks down the confusing, heartbreaking Sarepta saga"
"Sarepta Therapeutics' Duchenne therapy faces 'arduous' path back to market, senior FDA official says"
"For many Duchenne families, halt to gene therapy is heartbreak upon heartbreak"
"FDA launches probe into new Elevidys death as…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.